Triple Helix Alchemy
The computed 12-month bankruptcy probability of Triple Helix Alchemy is 2.1% (moderate). The 2024 annual accounts show equity of €6k and a net result of €-16k. Its solvency ranks better than 35% of 37 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €6k |
| Net result | €-16k |
| Better than sector | 35% |
| Active | 3 yrs |
Fragile profile, watch profitability in particular.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 1.1% | 18.2% | |
| Net result | €-16k | €-2k | |
| Equity | €6k | €82k | |
| Gross operating margin | €-9k | €52k | |
| Total assets | €546k | €1.74M |
Show 4 other metrics
| Fiscal year | 2024 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | - |
| Net profit | €-16k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €546k |
| Equity | €6k |
| Debt | €540k |
| of which ≤ 1y | €540k |
| of which > 1y | - |
| Working capital | €-492k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.09 |
| Quick ratio | 0.09 |
| Working capital ratio | -90.1% |
| Solvency | 1.1% |
| Debt / equity | 89.33 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -2.9% |
| ROE | -259.4% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (20 line items)
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €546k |
| Fixed assets | 21/28 | €498k |
| Financial fixed assets | 28 | €498k |
| Current assets | 29/58 | €48k |
| Amounts receivable within one year | 40/41 | €22k |
| Cash & bank | 54/58 | €26k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €546k |
| Equity | 10/15 | €6k |
| Contributions / capital | 10/11 | €25k |
| Accumulated profits (losses) | 14 | €-19k |
| Amounts payable | 17/49 | €540k |
| Amounts payable within one year | 42/48 | €540k |
| Trade debts payable within one year | 44 | €2k |
| Income statement | ||
| Gross operating margin | 9900 | €-9k |
| Operating result | 9901 | €-9k |
| Financial income | 75 | €633 |
| Financial charges | 65 | €8k |
| Result before taxes | 9903 | €-16k |
| Net result for the period | 9904 | €-16k |
| Result to be appropriated | 9905 | €-16k |
| NACE primary | Terugwinning van materialen uit afval(38210) |
| Legal form | Private limited company(610) |
| Incorporation | 14-03-2023 |
| Status | Active |
| Postal code | 2020 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11809I2910/00R000 | Flanders | 2,982 m² | 1 · 930 m² | 1.7 m |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
19-11-2024 Capital increase
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 25000.0,
"delta_eur": 23000.0,
"before_eur": 20000.0,
"subscribers": [
{
"kbo": "0782.932.530",
"rrn": null,
"kind": "org",
"name": "Triple Helix Molecules as a Service bv",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 7667,
"contribution_amount_eur": 23000.0
}
],
"share_emission": {
"agio_eur": 0.0,
"share_form": null,
"share_class": null,
"n_new_shares": 7667,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 3.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 23000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"_arith_inconsistent": true,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "create"
}
],
"notary": {
"name": "Nathalie Meert",
"firm_city": null,
"firm_name": null,
"office_city": "Antwerpen",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-11-19",
"filing_date": "2024-11-14",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-11-12",
"unanimous": true,
"under_authorized_capital": true,
"underlying_resolution_date": "2024-11-12"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0799.511.909",
"name_full": "Triple Helix Alchemy",
"legal_form": "B.V.",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"afschrift akte",
"co\u00F6rdinatie der statuten"
],
"shareholders_after": [
{
"kbo": "0782.932.530",
"pct": null,
"kind": "org",
"name": "Triple Helix Molecules as a Service bv",
"role": "aandeelhouder",
"n_shares": 7667,
"share_class": null
}
],
"share_classes_after": []
}| Legal nameNL | Triple Helix Alchemy |
| AbbreviationNL | THX Alchemy |